FeesSafety
Pluang+

Poor management and high debt cause RMR-managed REITs to underperform, hurting shareholders.

Market News
10 Nov 2026, 19:54 WIB
Seeking Alpha
View Source
Bearish
Poor management and high debt cause RMR-managed REITs to underperform, hurting shareholders.

RMR-managed REITs have consistently underperformed due to poor management quality, excessive debt, and shareholder dilution. This highlights the importance of skilled, shareholder-friendly management in the REIT sector, where active management can outperform passive benchmarks. Investors should be cautious of REITs with weak management and high leverage, as these factors can destroy value even if the assets are strong. The article is authored by Jussi Askola, a CFA and REIT investing expert, who shares insights through his High Yield Landlord group.

The article on 5 REITs to avoid offers context for readers following real estate investments. For readers following real estate stocks, here is Pluang's market snapshot as of Nov 10, 2026 23:41 WIB: Of 47 priced Real Estate-sector US stocks tradable on Pluang, 11 rose and 36 fell today. Notable movers include OUT at USD 31.81 with a 1-day change of +1.76%, IIPR at USD 54.57 down 1.75%, and GLPI at USD 38.82 down 1.57%.

More News

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

As of October 31, 2026, EssilorLuxottica disclosed its total number of shares at 464,247,548 and actual voting rights at 458,376,127 after deducting treasury shares. The company enforces a 31% voting rights cap per shareholder, as outlined in its sta...

Company Fundamentals
Neutral
1 hour ago
EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...

Company Fundamentals
Neutral
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
2 hours ago
Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
2 hours ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App